Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Sunitinib in Treating Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Radiation Therapy for Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE2